Crinetics Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (the "Shares") (CRNX)

88 filings reported holding CRNX - Crinetics Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (the "Shares") as of Q1 2021.
Crinetics Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (the "Shares") (CRNX) has 77 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 30.7M shares of 93.8M outstanding shares and own 32.71% of the company stock.
Largest 10 shareholders include FMR LLC (4.94M shares), PERCEPTIVE ADVISORS LLC (3.66M shares), ORBIMED ADVISORS LLC (2.75M shares), Vivo Capital, LLC (2.21M shares), BlackRock Inc. (2.17M shares), Versant Venture Management, LLC (2.03M shares), DRIEHAUS CAPITAL MANAGEMENT LLC (2M shares), 5AM Venture Management, LLC (1.36M shares), Point72 Asset Management, L.P. (1.28M shares), and VANGUARD GROUP INC (1.16M shares).
This table shows the top 77 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.